Seeking Alpha

Jazz Pharmaceuticals (JAZZ +2.8%) posts another gain after Friday's big post-Q2 earnings report...

Jazz Pharmaceuticals (JAZZ +2.8%) posts another gain after Friday's big post-Q2 earnings report jump. Jefferies upgrades shares to a Buy from Hold with a $52 price target noting the firm "previously modeled only 5% volume growth in '11-'13," but now sees "double-digit growth."
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs